Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.87
-0.1350-0.48%
Volume:17.23M
Turnover:476.53M
Market Cap:158.43B
PE:36.67
High:28.00
Open:27.90
Low:27.48
Close:28.00
52wk High:29.21
52wk Low:23.62
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.69
T/O Rate:0.31%
Dividend:1.72
Dividend Rate:6.17%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.86
PE(LYR):20.42

Loading ...

US Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 28

Pfizer to Present Phase 3 SigVie-002 Survival Data for Sigvotatug Vedotin in Previously Treated NSCLC at ESMO 2026

Reuters
·
Sep 28

Pfizer (PFE) Bets Big on RSV and Cancer Care

TIPRANKS
·
Sep 26

NYSE Most Active Issues

Dow Jones
·
Sep 26

Pfizer Targets Cancer-Related Weight Loss With New Ponsegromab Study

TIPRANKS
·
Sep 26

Pfizer’s RSV Revaccination Trial Targets Durable Booster Revenue in High‑Risk Adults

TIPRANKS
·
Sep 26

C4 Therapeutics Says Cemsidomide-Elranatamab Phase 1b Trial Clears 75 Μg Dose as Safe in Multiple Myeloma

Reuters
·
Sep 25

Moderately bullish activity in Pfizer with shares up 0.9%

TIPRANKS
·
Sep 25

Pfizer’s Japanese RSV Vaccine Study Wraps Up, Expanding Adult Market Potential

TIPRANKS
·
Sep 25

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

Pfizer call volume above normal and directionally bullish

TIPRANKS
·
Sep 24

RBC Capital Remains a Hold on Pfizer (PFE)

TIPRANKS
·
Sep 24

BridgeBio's Heart Drug Shows Superior Real-World Results Over Pfizer's Rival Treatment

Stock News
·
Sep 24

NYSE Most Active Issues

Dow Jones
·
Sep 24

BridgeBio Real-World Study Shows Attruby Cuts ATTR-CM Clinical Worsening Risk 34% vs Pfizer’s Tafamidis

Reuters
·
Sep 23

What Happens to Your Dividends When Interest Rates Stay Higher for Longer?

The Smart Investor
·
Sep 23

Press Release: Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts

Dow Jones
·
Sep 22

Pfizer Schedules Analyst Call Webcast on Quarterly Results Update

Reuters
·
Sep 22

Pfizer CEO Bourla Plans to Attend White House State Dinner for China's Xi, Source Says

Reuters
·
Sep 22

NYSE Most Active Issues

Dow Jones
·
Sep 22